Portal de Periódicos da CAPES

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

2023; Oxford University Press; Volume: 228; Issue: Supplement_2 Linguagem: Inglês

10.1093/infdis/jiad287

1537-6613

Mark J. Giganti, Kara W. Chew, Joseph J. Eron, Jonathan Z. Li, Mauricio Pinilla, Carlee Moser, Arzhang Cyrus Javan, William A. Fischer, Paul Klekotka, David M. Margolis, David A. Wohl, Robert W. Coombs, Eric S. Daar, Davey M. Smith, Judith S. Currier, Michael D. Hughes, Lara Hosey, Jhoanna Roa, Nilam Patel, Alexander L. Greninger, Emily Degli-Angeli, Erin Goecker, Glenda Daza, Socorro Harb, Joan Dragavon, Grace M. Aldrovandi, William Murtaugh, Frontier Science, Marlene Cooper, Howard Gutzman, Kevin Knowles, Rachel Bowman, Bill Erhardt, Lorraine Waring, Diane Hessinger, Stacey Adams,

COVID-19 Clinical Research Studies

There is little information regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA as a predictor for clinical outcomes in outpatients with mild-to-moderate coronavirus disease 2019 (COVID-19).